This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Brain Biomarkers Market

Market Insights on Brain Biomarkers covering sales outlook, demand forecast & up-to-date key trends

Brain Biomarkers Market By Product Type, Disease Indication, Application, End use & Region - Forecast 2022 – 2032

Brain Biomarkers Market Snapshot (2022-2032)

[250 Pages Report] The global brain biomarkers market is anticipated to exhibit growth at a CAGR of 14.3% in the forecast period from 2022 to 2032. It is set to reach US$ 8.3 Billion in 2022 and US$ 11.5 Billion in 2032. The rising prevalence of various neurological diseases, such as brain tumors, migraines, epilepsy, and dementia is projected to drive the sales of brain biomarkers in future years.

Report Attribute

Details

Brain Biomarkers Market Estimated Base Year Value (2021)

US$ 7.1 Billion

Brain Biomarkers Market Expected Market Value (2022)

US$ 8.3 Billion

Brain Biomarkers Market Anticipated Forecast Value (2032)

US$ 11.5 Billion

Brain Biomarkers Market Projected Growth Rate (2022-2032)

14.3% CAGR

Biomarkers are referred to as molecules that indicate the presence of a dysfunction or disease. These are becoming increasingly important for monitoring disease progression, selecting the best treatments, and confirming diagnoses.

Neurological biomarkers are mainly present in Cerebrospinal Fluid (CSF) and rarely in blood. These can be studied by using CSF, but require an invasive lumbar puncture procedure.

Biomarker signatures are considered to be another powerful tool for studying neurological conditions and diseases. These are detected with the help of panels of high-quality antibodies.

The development of genomic biomarkers is projected to create new opportunities for the introduction of diagnostics that are based on a person’s specific genetic variations. Genomic biomarkers are also expected to help in the creation of personalized medicines.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which are Some Major Factors Spurring Growth of the Brain Biomarkers Market

The ongoing technological advancement in the field of biomarkers and the emergence of biomarker signatures are expected to make neurological diseases more treatable. This is further expected to result in the early diagnosis, faster drug development, and non-invasive testing.

The launch of digital biomarkers by key players is set to deliver numerous pharmaceutical companies supplemental and contextual information to conclude clinical trials efficiently. Besides, government funding to accelerate research and development activities in various countries is expected to propel the demand for brain biomarkers in the assessment period.

Which Factors May Restrain the Brain Biomarkers Market Growth

The usage of brain biomarkers is limited to researchers for better understanding the disease progression. Several pharmaceutical and pathology companies worldwide are also using these to rapidly develop new therapeutics for neurodegenerative disorders. The lack of availability of commercial or direct-to-consumer tests may hamper the brain biomarkers market size in the near future.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Projected to Dominate the Brain Biomarkers Market

North America is anticipated to lead in terms of the brain biomarkers market share during the forthcoming years. This growth is attributable to the rising research funding by regulatory bodies and the surging acceptance of biomarkers for drug development purposes in the U.S. and Canada.

The increasing prevalence of various neurological diseases across these developed countries is another significant factor that is estimated to augur well for the market.

As per the Centers for Disease Control and Prevention (CDC), at present, nearly 5.8 million people have Alzheimer’s disease in the U.S. Cases of Alzheimer’s disease are expected to reach 14 million by 2060 in the country. These numbers are projected to grow at a fast pace, thereby propelling the North America market.

How is the Asia Pacific Brain Biomarkers Market Progressing

Asia Pacific is likely to exhibit a CAGR of 15.4% in the forecast period from 2022 to 2032. The rising number of clinical trials that are being conducted in China, Japan, India, and South Korea is projected to drive the Asia Pacific brain biomarkers market growth in future years.

The surging demand for targeted drugs to treat conditions associated with the central nervous system is another vital factor that is anticipated to augment the growth in the regional market. According to the National Health Portal, in India, the prevalence of dementia is set to be around 2.7%. This condition poses a great challenge in the country owing to the surging geriatric population. This factor is also expected to fuel the regional market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Majority of the key players operating in the global market are striving to incorporate the latest technologies to make it easier for researchers to track the condition of the brain by measuring its molecules. They are consistently developing innovative brain testing methods to provide new treatment options and enable faster diagnosis. Meanwhile, a few other key players are aiming to invest huge sums in clinical trials to boost new product development.

Some of the leading companies present in the global brain biomarkers market include Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, Johnson & Johnson, Natus Medical, F. Hoffmann-La Roche Ltd., Qiagen N.V., Nexus-DX, and NeuroVista among others.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 14.3% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Disease Indication
  • Application
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Siemens Healthineers
  • Electrical Geodesics
  • Lifesign LLC
  • Advanced Brain Monitoring
  • BrainScope
  • GE Healthcare
  • Johnson & Johnson
  • Natus Medical
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Nexus-DX
  • NeuroVista

Customization

Available Upon Request

Key Segments Profiled in the Brain Biomarkers Industry Survey

By Product Type:

  • Biomarker Test Kits
  • Biomarker Analyzers

By Disease Indication:

  • Stroke
  • MND & ALS
  • Alzheimer’s Disease & Other Dementias
  • Parkinson’s Disease
  • Huntington’s Disease

By Application:

  • Diagnosis
  • Drug Discovery and Development
  • Others

By End User:

  • Hospitals
  • Research Laboratories
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

The global brain biomarkers market is anticipated to surpass US$ 11.5 Billion in 2032.

North America is set to lead the brain biomarkers market in the forecast period.

Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, and Johnson & Johnson are some of the renowned companies in the brain biomarkers market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. Value Chain Analysis

        3.5.1. Profit Margin Analysis

        3.5.2. Service Providers

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Biomarkers

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Biomarkers, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Biomarkers, 2022-2032

        5.3.1. Genomics Biomarkers

        5.3.2. Proteomic Biomarkers

        5.3.3. Metabolomics Biomarkers

        5.3.4. Imaging Biomarkers

        5.3.5. Other Biomarkers

    5.4. Y-o-Y Growth Trend Analysis By Biomarkers, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Biomarkers, 2022-2032

Deep-dive segmentation will be available in the sample on request

6. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032

        6.3.1. Alzheimer’s Disease

        6.3.2. Parkinson’s Disease

        6.3.3. Huntington’s Disease

        6.3.4. Schizophrenia

        6.3.5. Depression

        6.3.6. Multiple Sclerosis

        6.3.7. Spinal Muscular Atrophy

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

Deep-dive segmentation will be available in the sample on request

7. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By End Users

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2032

        7.3.1. Academic & Research Institutes

        7.3.2. Diagnostic Laboratories

        7.3.3. Hospitals

    7.4. Y-o-Y Growth Trend Analysis By End Users, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End Users, 2022-2032

Deep-dive segmentation will be available in the sample on request

8. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia & Pacific

        8.3.6. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Biomarkers

        9.2.3. By Indication

        9.2.4. By End Users

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Biomarkers

        9.3.3. By Indication

        9.3.4. By End Users

    9.4. Key Takeaways

10. Latin America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Mexico

            10.2.1.2. Brazil

            10.2.1.3. Rest of Latin America

        10.2.2. By Biomarkers

        10.2.3. By Indication

        10.2.4. By End Users

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Biomarkers

        10.3.3. By Indication

        10.3.4. By End Users

    10.4. Key Takeaways

11. Europe Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. BENELUX

            11.2.1.7. Russia

            11.2.1.8. Rest of Europe

        11.2.2. By Biomarkers

        11.2.3. By Indication

        11.2.4. By End Users

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Biomarkers

        11.3.3. By Indication

        11.3.4. By End Users

    11.4. Key Takeaways

12. East Asia Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Biomarkers

        12.2.3. By Indication

        12.2.4. By End Users

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Biomarkers

        12.3.3. By Indication

        12.3.4. By End Users

    12.4. Key Takeaways

13. South Asia & Pacific Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. ASEAN

            13.2.1.3. Australia and New Zealand

            13.2.1.4. Rest of South Asia & Pacific

        13.2.2. By Biomarkers

        13.2.3. By Indication

        13.2.4. By End Users

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Biomarkers

        13.3.3. By Indication

        13.3.4. By End Users

    13.4. Key Takeaways

14. MEA Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Turkey

            14.2.1.3. South Africa

            14.2.1.4. Rest of MEA

        14.2.2. By Biomarkers

        14.2.3. By Indication

        14.2.4. By End Users

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Biomarkers

        14.3.3. By Indication

        14.3.4. By End Users

    14.4. Key Takeaways

15. Key Countries Brain Biomarkers Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Biomarkers

            15.1.2.2. By Indication

            15.1.2.3. By End Users

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Biomarkers

            15.2.2.2. By Indication

            15.2.2.3. By End Users

    15.3. Mexico

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Biomarkers

            15.3.2.2. By Indication

            15.3.2.3. By End Users

    15.4. Brazil

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Biomarkers

            15.4.2.2. By Indication

            15.4.2.3. By End Users

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Biomarkers

            15.5.2.2. By Indication

            15.5.2.3. By End Users

    15.6. Italy

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Biomarkers

            15.6.2.2. By Indication

            15.6.2.3. By End Users

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Biomarkers

            15.7.2.2. By Indication

            15.7.2.3. By End Users

    15.8. U.K.

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Biomarkers

            15.8.2.2. By Indication

            15.8.2.3. By End Users

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Biomarkers

            15.9.2.2. By Indication

            15.9.2.3. By End Users

    15.10. BENELUX

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Biomarkers

            15.10.2.2. By Indication

            15.10.2.3. By End Users

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Biomarkers

            15.11.2.2. By Indication

            15.11.2.3. By End Users

    15.12. China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Biomarkers

            15.12.2.2. By Indication

            15.12.2.3. By End Users

    15.13. Japan

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Biomarkers

            15.13.2.2. By Indication

            15.13.2.3. By End Users

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Biomarkers

            15.14.2.2. By Indication

            15.14.2.3. By End Users

    15.15. India

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Biomarkers

            15.15.2.2. By Indication

            15.15.2.3. By End Users

    15.16. ASEAN

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Biomarkers

            15.16.2.2. By Indication

            15.16.2.3. By End Users

    15.17. Australia and New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Biomarkers

            15.17.2.2. By Indication

            15.17.2.3. By End Users

    15.18. GCC Countries

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Biomarkers

            15.18.2.2. By Indication

            15.18.2.3. By End Users

    15.19. Turkey

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Biomarkers

            15.19.2.2. By Indication

            15.19.2.3. By End Users

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Biomarkers

            15.20.2.2. By Indication

            15.20.2.3. By End Users

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Biomarkers

        16.3.3. By Indication

        16.3.4. By End Users

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Merck KGaA

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Quanterix

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Myriad RBM

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. QIAGEN

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. ADx NeuroSciences NV

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Thermo Fisher Scientific

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. BioAgilytix

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. ACOBIOM

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Banyan Biomarkers, Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Olink Biosciences

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. Illumina, Inc.

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 3: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 4: Global Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 5: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 7: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 8: North America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 9: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 11: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 12: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 13: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 15: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 16: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 17: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 19: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 20: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 21: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 23: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 24: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 25: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 27: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 28: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 29: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Table 30: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Table 31: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Table 32: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Table 33: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Table 34: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Table 35: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Table 36: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Table 37: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Table 38: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Table 39: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 2: Global Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 3: Global Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 4: Global Brain Biomarkers Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 9: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 10: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 11: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 12: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 13: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 14: Global Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 15: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 16: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 17: Global Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 18: Global Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 19: Global Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 20: Global Brain Biomarkers Market Attractiveness by Region, 2022-2032

Figure 21: North America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 22: North America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 23: North America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 24: North America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 29: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 30: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 31: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 32: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 33: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 34: North America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 35: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 36: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 37: North America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 38: North America Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 39: North America Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 40: North America Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 42: Latin America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 43: Latin America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 44: Latin America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 49: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 50: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 51: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 52: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 53: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 54: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 55: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 56: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 57: Latin America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 58: Latin America Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 59: Latin America Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 60: Latin America Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 61: Europe Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 62: Europe Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 63: Europe Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 64: Europe Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 69: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 70: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 71: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 72: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 73: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 74: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 75: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 76: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 77: Europe Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 78: Europe Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 79: Europe Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 80: Europe Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 81: East Asia Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 82: East Asia Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 83: East Asia Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 84: East Asia Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 85: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 89: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 90: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 91: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 92: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 93: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 94: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 95: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 96: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 97: East Asia Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 98: East Asia Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 99: East Asia Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 100: East Asia Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 101: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 102: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 103: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 104: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 105: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 109: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 110: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 111: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 112: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 113: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 114: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 115: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 116: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 117: South Asia & Pacific Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 118: South Asia & Pacific Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 119: South Asia & Pacific Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 120: South Asia & Pacific Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 121: MEA Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 122: MEA Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 123: MEA Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 124: MEA Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 125: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 129: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 130: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 131: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 132: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 133: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 134: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 135: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 136: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 137: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 138: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 139: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 140: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Brain Implants Market

Published : June 2022

Healthcare

Brain Metastasis Therapeutics Market

Published : April 2016

Healthcare

Brain Tumor Treatment Market

Published : January 1970

Healthcare

Brain Monitoring Systems Market

Published : March 2022

Google translate

Brain Biomarkers Market